Novo Nordisk is Denmark’s largest company, leading globally in diabetes care and innovative biopharmaceutical treatments worldwide.
The second-largest pharmaceutical company in Denmark is Lundbeck, specialising in treatments for neurological and psychiatric disorders.
Denmark’s pharmaceutical industry features innovative mid-sized firms, strong research links, and global exports, particularly in biotech and specialized therapeutics.